{
    "nctId": "NCT02765217",
    "officialTitle": "Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children: Prospective, Multi-center, Randomize, Parallel Group Placebo Controlled Clinical Trial",
    "inclusionCriteria": "\u2022 Children receiving amoxicilline-clavulanic acid (50-90 mg/kg/day, twice daily) due to acute otitis media or acute sinusitis\n* Must have minimum age of 6 Months\n* Must have maximum age of 18 Years",
    "exclusionCriteria": "* Receiving antibiotic and/or probiotic, 8 weeks before the study\n* Chronic gastrointestinal system disorders\n* Congenital anomalies\n* Chronic diseases\n* Chemotherapy and radiotherapy\n* Pregnancy"
}